Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1951 1
1952 1
1954 4
1955 1
1957 2
1958 6
1960 3
1961 2
1962 9
1963 2
1965 7
1966 13
1967 17
1968 12
1969 12
1970 14
1971 6
1972 11
1973 8
1974 11
1975 15
1976 14
1977 11
1978 13
1979 22
1980 16
1981 24
1982 42
1983 49
1984 58
1985 65
1986 68
1987 58
1988 50
1989 54
1990 69
1991 65
1992 71
1993 60
1994 86
1995 88
1996 120
1997 91
1998 110
1999 104
2000 107
2001 131
2002 122
2003 115
2004 96
2005 108
2006 130
2007 145
2008 108
2009 103
2010 109
2011 125
2012 138
2013 159
2014 139
2015 152
2016 158
2017 202
2018 255
2019 225
2020 269
2021 297
2022 264
2023 192
2024 88

Text availability

Article attribute

Article type

Publication date

Search Results

5,038 results

Results by year

Filters applied: . Clear all
Page 1
HNF1A Mutations and Beta Cell Dysfunction in Diabetes.
Miyachi Y, Miyazawa T, Ogawa Y. Miyachi Y, et al. Among authors: ogawa y. Int J Mol Sci. 2022 Mar 16;23(6):3222. doi: 10.3390/ijms23063222. Int J Mol Sci. 2022. PMID: 35328643 Free PMC article. Review.
Corrigendum.
Wilts BD, Rudall PJ, Moyroud E, Gregory T, Ogawa Y, Vignolini S, Steiner U, Glover BJ. Wilts BD, et al. Among authors: ogawa y. New Phytol. 2022 Oct;236(2):792. doi: 10.1111/nph.18406. Epub 2022 Aug 7. New Phytol. 2022. PMID: 35933737 Free PMC article. No abstract available.
Medium-chain fatty acids suppress lipotoxicity-induced hepatic fibrosis via the immunomodulating receptor GPR84.
Ohue-Kitano R, Nonaka H, Nishida A, Masujima Y, Takahashi D, Ikeda T, Uwamizu A, Tanaka M, Kohjima M, Igarashi M, Katoh H, Tanaka T, Inoue A, Suganami T, Hase K, Ogawa Y, Aoki J, Kimura I. Ohue-Kitano R, et al. Among authors: ogawa y. JCI Insight. 2023 Jan 24;8(2):e165469. doi: 10.1172/jci.insight.165469. JCI Insight. 2023. PMID: 36480287 Free PMC article.
Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.
Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, Izawa S, Ichijo T, Otsuki M, Omura M, Ogawa Y, Oki Y, Kurihara I, Kobayashi H, Sakamoto R, Satoh F, Takeda Y, Tanaka T, Tamura K, Tsuiki M, Hashimoto S, Hasegawa T, Yoshimoto T, Yoneda T, Yamamoto K, Rakugi H, Wada N, Saiki A, Ohno Y, Haze T. Naruse M, et al. Among authors: ogawa y. Endocr J. 2022 Apr 28;69(4):327-359. doi: 10.1507/endocrj.EJ21-0508. Epub 2022 Apr 12. Endocr J. 2022. PMID: 35418526 Free article.
Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH.
Itoh M, Tamura A, Kanai S, Tanaka M, Kanamori Y, Shirakawa I, Ito A, Oka Y, Hidaka I, Takami T, Honda Y, Maeda M, Saito Y, Murata Y, Matozaki T, Nakajima A, Kataoka Y, Ogi T, Ogawa Y, Suganami T. Itoh M, et al. Among authors: ogawa y. J Exp Med. 2023 Nov 6;220(11):e20220681. doi: 10.1084/jem.20220681. Epub 2023 Sep 19. J Exp Med. 2023. PMID: 37725372 Free PMC article.
A prospective, multicenter, open-label phase III study of emicizumab prophylaxis in patients with acquired hemophilia A.
Shima M, Amano K, Ogawa Y, Yoneyama K, Ozaki R, Kobayashi R, Sakaida E, Saito M, Okamura T, Ito T, Hattori N, Higasa S, Suzuki N, Seki Y, Nogami K. Shima M, et al. Among authors: ogawa y. J Thromb Haemost. 2023 Mar;21(3):534-545. doi: 10.1016/j.jtha.2022.10.004. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36696195 Free article. Clinical Trial.
Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023.
Matsumoto M, Miyakawa Y, Kokame K, Ueda Y, Wada H, Higasa S, Yagi H, Ogawa Y, Sakai K, Miyata T, Morishita E, Fujimura Y; For TTP group of Blood Coagulation Abnormalities Research Study Team, Research on Rare and Intractable diseases, Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan. Matsumoto M, et al. Among authors: ogawa y. Int J Hematol. 2023 Nov;118(5):529-546. doi: 10.1007/s12185-023-03657-0. Epub 2023 Sep 10. Int J Hematol. 2023. PMID: 37689812 Free PMC article.
Chilblain Lupus Erythematosus.
Shimamura Y, Ogawa Y, Takizawa H. Shimamura Y, et al. Among authors: ogawa y. JMA J. 2021 Oct 15;4(4):423-425. doi: 10.31662/jmaj.2021-0064. Epub 2021 Sep 1. JMA J. 2021. PMID: 34796299 Free PMC article. No abstract available.
Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial.
Kadowaki T, Chin R, Ozeki A, Imaoka T, Ogawa Y. Kadowaki T, et al. Among authors: ogawa y. Lancet Diabetes Endocrinol. 2022 Sep;10(9):634-644. doi: 10.1016/S2213-8587(22)00187-5. Epub 2022 Jul 30. Lancet Diabetes Endocrinol. 2022. PMID: 35914542 Clinical Trial.
5,038 results